Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
NCT00126022
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Atrial Fibrillation
Atrial Flutter
Interventions
DRUG:
Tedisamil sesquifumarate
Sponsor
Solvay Pharmaceuticals